BAKER-GLENN, CHARLES C/O BIOFOCUS,BURDICK, DANIEL JON C/O GENENTECH, INC,CHAMBERS, MARK C/O BIOFOCUS,CHEN, HUIFEN C/O GENENTECH, INC.,ESTRADA, ANTHONY C/O GENENTECH, INC.,SWEENEY, ZACHARY KEVIN C/O GE
申请号：
PT16180927
公开号：
PT3124483T
申请日:
2011.11.09
申请国别(地区):
PT
年份:
2019
代理人:
摘要：
Compounds of the formula I: or pharmaceutically acceptable salts thereof, wherein X, R 1 , R 2 , R 3 , R 4 and R 5 are as defined herein. Also disclosed are methods of making the compounds and using the compounds for treatment of diseases associated with LRRK2 receptor, such as Parkinson's disease.
